Docoh
Loading...

AFIB Acutus Medical

News

From Benzinga Pro
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
20 Jan 22
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Upgrades
Stocks That Hit 52-Week Lows On Thursday
20 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Thursday's morning trading, 152 companies set new 52-week lows.
BTIG Downgrades Acutus Medical to Neutral
20 Jan 22
News, Downgrades, Analyst Ratings
BTIG analyst Marie Thibault downgrades Acutus Medical (NASDAQ:AFIB) from Buy to Neutral.
Acutus Medical Plans Job Cuts; Preliminary Q4, FY21 Sales Exceed Estimates
19 Jan 22
Earnings, News, Penny Stocks, Guidance, Health Care, General
Acutus Medical Inc (NASDAQ: AFIB) will cut its workforce and implement additional cost reduction measures
12 Health Care Stocks Moving In Friday's Intraday Session
14 Jan 22
Intraday Update, Markets, Movers
Stocks That Hit 52-Week Lows On Friday
14 Jan 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Friday's session, 445 companies made new 52-week lows.
Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2022
14 Jan 22
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Upgrades
Canaccord Genuity Downgrades Acutus Medical to Hold, Lowers Price Target to $3
14 Jan 22
News, Downgrades, Price Target, Analyst Ratings
Canaccord Genuity analyst William Plovanic downgrades Acutus Medical (NASDAQ:AFIB) from Buy to Hold and lowers the price target from $10 to $3.
Acutus Medical's Pulsed Field Ablation System To Be Featured During 27th Annual AF Symposium
13 Jan 22
News, Events
Acutus Medical, Inc. (“Acutus”) (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the company’s attendance at
Overview Of Value Stocks In The Healthcare Sector
29 Nov 21
News
What are Value Stocks?
12 Health Care Stocks Moving In Wednesday's After-Market Session
24 Nov 21
Movers
Gainers
70 Biggest Movers From Friday
15 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
Mid-Afternoon Market Update: Dow Surges 150 Points; Team Shares Drop
12 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Friday, the Dow traded up 0.42% to 36,071.48 while the NASDAQ rose 0.84% to 15,835.89. The S&P also rose, gaining 0.61% to 4,677.60.
Mid-Day Market Update: Everspin Jumps After Q3 Results; Acutus Medical Shares Plummet
12 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Midway through trading Friday, the Dow traded up 0.31% to 36,031.95 while the NASDAQ rose 0.54% to 15,788.64. The S&P also rose, gaining 0.43% to 4,669.15.
48 Stocks Moving In Friday's Mid-Day Session
12 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares climbed 41% to $9.28 after the company reported better-than-expected Q3results and issued Q4 sales guidance above estimates.
Mid-Morning Market Update: Markets Rise; AstraZeneca's COVID-19 Vaccine Turns Profitable In Third Quarter
12 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Friday, the Dow traded up 0.25% to 36,012.29 while the NASDAQ rose 0.24% to 15,741.23. The S&P also rose, gaining 0.14% to 4,655.99.
Benzinga's Top Ratings Upgrades, Downgrades For November 12, 2021
12 Nov 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
JP Morgan Downgrades Acutus Medical to Underweight
12 Nov 21
News, Downgrades, Analyst Ratings
JP Morgan analyst Robbie Marcus downgrades Acutus Medical (NASDAQ:AFIB) from Neutral to Underweight.
Canaccord Genuity Maintains Buy on Acutus Medical, Lowers Price Target to $10
12 Nov 21
News, Price Target, Analyst Ratings
Canaccord Genuity analyst William Plovanic maintains Acutus Medical (NASDAQ:AFIB) with a Buy and lowers the price target from $18 to $10.
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
12 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Small Cap, General
Here's a roundup of top developments in the biotech space over the last 24 hours.

Press releases

From Benzinga Pro
(AFIB) News: Did You Lose Money on Your Acutus Medical Stock? Contact Johnson Fistel Regarding Class Action Investigation
25 Jan 22
News, Legal, Press Releases
SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Acutus Medical, Inc. ("Acutus " or "the
Acutus Medical Announces Restructuring and Preliminary, Unaudited Fourth Quarter and Full Year 2021 Revenue
19 Jan 22
Press Releases
CARLSBAD, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
Acutus Medical's Pulsed Field Ablation System To Be Featured During 27th Annual AF Symposium
13 Jan 22
News, Health Care, Press Releases
CARLSBAD, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today
Acutus Medical Initiates CE Mark Study for Focal Pulsed Field Ablation Therapy to Treat Atrial Fibrillation
11 Nov 21
Health Care, Press Releases
CARLSBAD, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (NASDAQ:AFIB) ("Acutus"), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today
Acutus Medical Reports Third Quarter 2021 Financial Results
11 Nov 21
Earnings, Press Releases
CARLSBAD, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and
Acutus Medical to Announce Third Quarter 2021 Financial Results
28 Oct 21
News, Markets, Press Releases
CARLSBAD, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus") (NASDAQ:AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced